417 related articles for article (PubMed ID: 12072066)
1. Topical corticosteroid therapy for acute radiation dermatitis: a prospective, randomized, double-blind study.
Schmuth M; Wimmer MA; Hofer S; Sztankay A; Weinlich G; Linder DM; Elias PM; Fritsch PO; Fritsch E
Br J Dermatol; 2002 Jun; 146(6):983-91. PubMed ID: 12072066
[TBL] [Abstract][Full Text] [Related]
2. Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double-blind, randomized study.
Boström A; Lindman H; Swartling C; Berne B; Bergh J
Radiother Oncol; 2001 Jun; 59(3):257-65. PubMed ID: 11369066
[TBL] [Abstract][Full Text] [Related]
3. Topical Ectoin Versus Topical Dexpanthenol for Managing Acute Radiodermatitis Associated With Breast Cancer Radiotherapy: A Randomized Double-Blind Study.
Abd Elazim NE; Awad SM; El-Naggar MS; Mohamed RH
Dermatitis; 2023; 34(6):516-524. PubMed ID: 37792331
[No Abstract] [Full Text] [Related]
4. Retrospective study of radiotherapy-induced skin reactions in breast cancer patients: reduced incidence of moist desquamation with a hydroactive colloid gel versus dexpanthenol.
Censabella S; Claes S; Orlandini M; Braekers R; Thijs H; Bulens P
Eur J Oncol Nurs; 2014 Oct; 18(5):499-504. PubMed ID: 24877859
[TBL] [Abstract][Full Text] [Related]
5. A potent steroid cream is superior to emollients in reducing acute radiation dermatitis in breast cancer patients treated with adjuvant radiotherapy. A randomised study of betamethasone versus two moisturizing creams.
Ulff E; Maroti M; Serup J; Falkmer U
Radiother Oncol; 2013 Aug; 108(2):287-92. PubMed ID: 23827771
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic treatment with a potent corticosteroid cream ameliorates radiodermatitis, independent of radiation schedule: A randomized double blinded study.
Ulff E; Maroti M; Serup J; Nilsson M; Falkmer U
Radiother Oncol; 2017 Jan; 122(1):50-53. PubMed ID: 27913066
[TBL] [Abstract][Full Text] [Related]
7. Topical use of recombinant human epidermal growth factor (EGF)-based cream to prevent radiation dermatitis in breast cancer patients: a single-blind randomized preliminary study.
Kong M; Hong SE
Asian Pac J Cancer Prev; 2013; 14(8):4859-64. PubMed ID: 24083759
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind trial on the use of 1% hydrocortisone cream for the prevention of acute radiation dermatitis.
Meghrajani CF; Co HS; Arcillas JG; Maaño CC; Cupino NA
Expert Rev Clin Pharmacol; 2016; 9(3):483-91. PubMed ID: 26619355
[TBL] [Abstract][Full Text] [Related]
9. Randomized, Prospective, Open-label Phase III Trial Comparing Mebo Ointment With Biafine Cream for the Management of Acute Dermatitis During Radiotherapy for Breast Cancer.
Geara FB; Eid T; Zouain N; Thebian R; Andraos T; Chehab C; Ramia P; Youssef B; Zeidan YH
Am J Clin Oncol; 2018 Dec; 41(12):1257-1262. PubMed ID: 29889137
[TBL] [Abstract][Full Text] [Related]
10. [Skin care in deep radiotherapy].
Panizzon RG; Mirimanoff RO
Hautarzt; 2001 Feb; 52(2):150. PubMed ID: 11244895
[No Abstract] [Full Text] [Related]
11. Efficacy of a hydroactive colloid gel versus historical controls for the prevention of radiotherapy-induced moist desquamation in breast cancer patients.
Censabella S; Claes S; Orlandini M; Braekers R; Bulens P
Eur J Oncol Nurs; 2017 Aug; 29():1-7. PubMed ID: 28720256
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of topical hydrating and emollient lotion containing 10% urea ISDIN® plus dexpanthenol (Ureadin Rx 10) in the treatment of skin xerosis and pruritus in hemodialyzed patients: an open prospective pilot trial.
Castello M; Milani M
G Ital Dermatol Venereol; 2011 Oct; 146(5):321-5. PubMed ID: 21956268
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of dexpanthenol in skin protection against irritation: a double-blind, placebo-controlled study.
Biro K; Thaçi D; Ochsendorf FR; Kaufmann R; Boehncke WH
Contact Dermatitis; 2003 Aug; 49(2):80-4. PubMed ID: 14641355
[TBL] [Abstract][Full Text] [Related]
14. Investigation of some topical formulations containing dexpanthenol.
Stozkowska W; Piekoś R
Acta Pol Pharm; 2004; 61(6):433-7. PubMed ID: 15794335
[TBL] [Abstract][Full Text] [Related]
15. Comparison of dexpanthenol and zinc oxide ointment with ointment base in the treatment of irritant diaper dermatitis from diarrhea: a multicenter study.
Wananukul S; Limpongsanuruk W; Singalavanija S; Wisuthsarewong W
J Med Assoc Thai; 2006 Oct; 89(10):1654-8. PubMed ID: 17128840
[TBL] [Abstract][Full Text] [Related]
16. Effect of topically applied dexpanthenol on epidermal barrier function and stratum corneum hydration. Results of a human in vivo study.
Gehring W; Gloor M
Arzneimittelforschung; 2000 Jul; 50(7):659-63. PubMed ID: 10965426
[TBL] [Abstract][Full Text] [Related]
17. Topical use of dexpanthenol in skin disorders.
Ebner F; Heller A; Rippke F; Tausch I
Am J Clin Dermatol; 2002; 3(6):427-33. PubMed ID: 12113650
[TBL] [Abstract][Full Text] [Related]
18. Treatment of acute radiodermatitis with an oil-in-water emulsion following radiation therapy for breast cancer: a controlled, randomized trial.
Jensen JM; Gau T; Schultze J; Lemmnitz G; Fölster-Holst R; May T; Abels C; Proksch E
Strahlenther Onkol; 2011 Jun; 187(6):378-84. PubMed ID: 21603988
[TBL] [Abstract][Full Text] [Related]
19. Topical atorvastatin 1% for prevention of skin toxicity in patients receiving radiation therapy for breast cancer: a randomized, double-blind, placebo-controlled trial.
Ghasemi A; Ghashghai Z; Akbari J; Yazdani-Charati J; Salehifar E; Hosseinimehr SJ
Eur J Clin Pharmacol; 2019 Feb; 75(2):171-178. PubMed ID: 30291370
[TBL] [Abstract][Full Text] [Related]
20. Optimal Topical Agent for Radiation Dermatitis During Breast Radiotherapy: A Pilot Study.
Fenton-Kerimian M; Cartwright F; Peat E; Florentino R; Maisonet O; Budin W; Rolnitzky L; Formenti S
Clin J Oncol Nurs; 2015 Aug; 19(4):451-5. PubMed ID: 26207710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
